Longeveron Inc., a pioneering biotechnology company headquartered in the United States, focuses on developing innovative cell therapies to address age-related and degenerative diseases. Founded in 2014, Longeveron has made significant strides in the field of regenerative medicine, particularly with its unique product offerings centred around mesenchymal stem cells (MSCs). The company’s flagship therapies aim to enhance healthspan and improve quality of life for patients suffering from conditions such as frailty and heart disease. Longeveron has established a strong market position, recognised for its commitment to scientific excellence and patient-centric solutions. With ongoing clinical trials and collaborations, Longeveron continues to lead the way in advancing the future of cellular therapies.
How does Longeveron Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Longeveron Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Longeveron Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Longeveron Inc. may still be in the early stages of developing a comprehensive climate strategy. As the company progresses, it may consider establishing measurable targets aligned with industry standards to enhance its sustainability profile and address climate change effectively.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Longeveron Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
